首页> 美国卫生研究院文献>other >Stent-Jailing Technique Reduces Aneurysm Recurrence More Than Stent-Jack Technique by Causing Less Mechanical Forces and Angiogenesis and Inhibiting TGF-β/Smad234 Signaling Pathway in Intracranial Aneurysm Patients
【2h】

Stent-Jailing Technique Reduces Aneurysm Recurrence More Than Stent-Jack Technique by Causing Less Mechanical Forces and Angiogenesis and Inhibiting TGF-β/Smad234 Signaling Pathway in Intracranial Aneurysm Patients

机译:冠脉支架技术通过减少机械力和血管生成并抑制颅内动脉瘤患者的TGF-β/ Smad234信号通路比支架支架技术减少了更多的动脉瘤复发。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Stent-jailing and stent-jack are used for stent-assisted coil embolism (SCE) in intracranial aneurysm (IA) therapy, and cause different incidences of IA recurrence. Angiogenesis strongly correlates with aneurysm accumulation. Stent-jack causes higher mechanical forces in cerebral vessels than stent-jailing. Mechanical forces, as well as TGF-β/Smad2,3,4 signaling pathway, may play an important factor in IA recurrence by affecting angiogenesis.>Methods: We explored the effects of stent-jailing or stent-jack technique on IA recurrence by investigating mechanical forces, TGF-β/Smad2,3,4 signaling pathway and the incidence of angiogenesis in IA patients. One-hundred-eighty-one IA patients were assigned into stent-jailing (n = 93) and stent-jacket groups (n = 88). The clinical outcome was evaluated using Glasgow Outcome Score (GOS) and aneurysm occlusion grades. The percentage of CD34+EPCs (releasing pro-angiogenic cytokines) in peripheral blood was measured by flow cytometer. Endothelial cells were separated from cerebral aneurysm and malformed arteries via immunomagnetic cell sorting. Angiogenesis was measured by microvessel density (MVD) using anti-CD34 monoclonal antibody staining before using the stent, immediately after surgery and 2 years later. Meanwhile, the mechanical forces in cerebral vessels were determined by measuring endothelial shear stress (ESS) via a computational method. TGF-β and Smad2,3,4 were measured by real-time qPCR and Western Blot. Tube formation analysis was performed to test the relationship between angiogenesis and TGF-β, and the effects of different techniques on angiogenesis.>Results: After a 2-year follow-up, 85 and 81 patients from stent-jailing and stent-jack groups, respectively, completed the experiment. Stent-jailing technique improved GOS and reduced aneurysm occlusion grades higher than the stent-jack technique (P < 0.05). The counts of CD34+EPCs and MVD values in the stent-jailing group were lower than the stent-jack group (P < 0.05). ESS values in sent-jailing group were lower than the stent-jack group (P < 0.05), and positively correlated with MVD values (P < 0.05). TGF-β and Smad2,3,4 levels in sent-jailing group were also lower than the stent-jack group (P < 0.05). TGF-β was associated with angiogenesis incidence and stent-jack caused angiogenesis incidence more than stent-jailing.>Conclusion: Stent-jailing technique reduces IA recurrence more than stent-jack by causing less mechanical forces, angiogenesis and inhibiting TGF-β/Smad2,3,4 signaling in IA patients.
机译:>背景:在颅内动脉瘤(IA)治疗中,支架置入术和支架起重器用于支架辅助线圈栓塞(SCE),并导致不同的IA复发率。血管生成与动脉瘤的积累密切相关。支架起重器在脑血管中比支架起重器产生更高的机械力。机械力以及TGF-β/ Smad2,3,4信号通路可能通过影响血管生成而在IA复发中发挥重要作用。>方法:我们探讨了支架置入或支架置入的影响通过研究机械力,TGF-β/ Smad2,3,4信号通路和IA患者血管新生的发生率,研究杰克技术对IA复发的影响。 181例IA患者被分为支架-支架组(n = 93)和支架-支架组(n = 88)。临床结果使用格拉斯哥结果评分(GOS)和动脉瘤闭塞等级进行评估。用流式细胞仪测定外周血中CD34 + EPCs(释放促血管生成细胞因子)的百分比。通过免疫磁性细胞分选,将内皮细胞与脑动脉瘤和畸形动脉分离。在使用支架之前,手术后立即和2年后,使用抗CD34单克隆抗体染色通过微血管密度(MVD)测量血管生成。同时,通过计算方法通过测量内皮切应力(ESS)确定脑血管中的机械力。通过实时qPCR和Western Blot测量TGF-β和Smad2,3,4。进行管形成分析以测试血管生成与TGF-β的关系,以及不同技术对血管生成的影响。>结果:经过2年的随访,分别有85例和81例来自支架的患者jaail组和Jack-jack组分别完成了实验。支架置入术比支架置入术具有更高的GOS,并降低了动脉瘤的闭塞程度(P <0.05)。覆膜支架组的CD34 + EPCs和MVD值均低于覆膜支架组(P <0.05)。入狱组的ESS值低于支架置入组(P <0.05),与MVD值呈正相关(P <0.05)。入狱组TGF-β和Smad2,3,4水平也均低于支架置入组(P <0.05)。 TGF-β与血管生成发生率相关,支架起重引起的血管生成发生率比支架发生率高。>结论:支架置入技术通过减少机械力,血管生成和血管生成,比支架起搏器更能减少IA复发。抑制IA患者的TGF-β/ Smad2,3,4信号传导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号